1The Scandinavian Simvastatin Survival Study Group. Randomised trail of cholesterol lowering in 4444 patients with coronary heart disease(4S) [J]. Lancet, 1994,344(8) : 1383 - 1389
2The Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trail results: Reduction in incidence of coronary heart disease[ J]. JAMA, 1984,251 (6) : 351 - 370
3Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia(WOSCOPS) [ J ]. New Engl J Med, 1995,333(2) : 1301 - 1370.
4Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes(MIRACL) [J]. JAMA,2001,285(13) : 1711 - 1718
5Heart Protection Study Collaborative Group.Heart protection study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals (HPS) [J].Lancet,2002,360(1) :7 - 22
6Sever PS, Dahlff B, Poulter NR, et al.Preventiou of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the anglo-scandinavian cardiac outcomes trial lipid lowering arm (ASCOT-LLA) [J] .Lancet,2003, 361(12) : 1149 - 1158
7Colhouri HM, Betteride D J, Durring PN, et al. Primary prevention of cardiovaseular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study(CARDS) [J] .Lancet, 2004, 364(3) : 685 - 696
8Okazaki S. Early statin treatment in patients with acute coronary syndrome (ESTABLIH) [J]. Circulation,2004,110(6) : 1061 - 1068
9Taylor AJ, Sullenberger LE,Lee HJ, et al.Arerial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) [ J ]. Circulation,2004,110(9) :3512 - 3517
10Nisscn S. Design and methodology of a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden (ASTEROID) [ J]. Atheroscler Suppl, 2006,84( 1 ) : 4 - 27
